Conclusion Of Non-Exclusive Discount Agreements According To § 130A Abs. 8 Sgb V For The Active Ingredient Peginterferon Beta-1A

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 66186883

  Document Type - Tender Notices

Description - §130a paragraph 8 SGB V enables the health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements on the drugs to be dispensed at the expense of the statutory KK. The GWQ acts as a company for efficiency and quality at KK according to § 130a paragraph 8 sentence 5 SGB V for its shareholders and customers. With regard to the relevant legal regulations for the award of public contracts, a regular process of active ingredient-related, formal award procedures takes place according to the regulations of Part 4 of the GWB by GWQ ServicePlus AG. Until the new drug discount agreements come into force, the GWQ would like to conclude drug discount agreements

Gt Ref Id - 66186883

Deadline - May 09, 2025